Abstract

Interleukin (IL)-23 is a heterodimeric cytokine composed of a unique p19 subunit, and a common p40 subunit shared with IL-12. IL-12 is important for the development of T helper (Th)1 cells that are essential for host defense and tumor suppression. In contrast, IL-23 does not promote the development of interferon-γ–producing Th1 cells, but is one of the essential factors required for the expansion of a pathogenic CD4+ T cell population, which is characterized by the production of IL-17, IL-17F, IL-6, and tumor necrosis factor. Gene expression analysis of IL-23–driven autoreactive T cells identified a unique expression pattern of proinflammatory cytokines and other novel factors, distinguishing them from IL-12–driven T cells. Using passive transfer studies, we confirm that these IL-23–dependent CD4+ T cells are highly pathogenic and essential for the establishment of organ-specific inflammation associated with central nervous system autoimmunity.

Keywords

BiologyImmunologyProinflammatory cytokineInflammationAutoimmunityInterleukin 23PopulationTumor necrosis factor alphaT helper cellT cellInterleukin 12CytokineCell biologyImmune systemInterleukin 17Cytotoxic T cellMedicineGenetics

Related Publications

Blockade of Interleukin-6 Signaling Suppresses Not Only Th17 but Also Interphotoreceptor Retinoid Binding Protein–Specific Th1 by Promoting Regulatory T Cells in Experimental Autoimmune Uveoretinitis

PURPOSE. Both Th17 and Th1 cells contribute to experimental autoimmune uveoretinitis (EAU). Interleukin-6 (IL-6) blockade inhibits Th17 differentiation in EAU and potently suppr...

2011 Investigative Ophthalmology & Visual ... 73 citations

Publication Info

Year
2005
Type
article
Volume
201
Issue
2
Pages
233-240
Citations
3991
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

3991
OpenAlex

Cite This

Claire L. Langrish, Yi Chen, Wendy M. Blumenschein et al. (2005). IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. The Journal of Experimental Medicine , 201 (2) , 233-240. https://doi.org/10.1084/jem.20041257

Identifiers

DOI
10.1084/jem.20041257